Quality of life correlations in patients with Erythropoietic Protoporphyria and X-Linked Protoporphyria on Afamelanotide: A retrospective cohort study - Supplemental Figure 1
Published: 7 July 2022| Version 2 | DOI: 10.17632/7tcss39myf.2
Contributors:
, , , , Description
Investigating the impact of therapeutic response to afamelanotide on quality of life in patients with erythropoietic protoporphyria and x-linked protoporphyria.
Files
Institutions
Henry Ford Hospital
Categories
Dermatology